Academic and author Tom Bellamy, author of the book Smitten, explains how to recognize the signs of limerence, a romantic ...

Roughly one out of every two people who start taking semaglutide (Wegovy; Novo Nordisk) to lose weight will stop taking the ...

Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers ...

Despite its dramatic ability to cut pounds by curbing appetite, high costs, unpleasant side effects, and health complications drive many users away. Younger adults and men are especially likely to ...

It may sound trivial, but experts warn that a long-term itch should never be dismissed. It can be a warning sign of an ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...

Therapists naturally wish to always move forward and make progress, but accepting limitations is powerful. Saying goodbye can ...

Patients with Graves disease who taper methimazole to a maintenance dose of 1.25 mg/day before discontinuing the drug experience improved remission rates compared to those on higher doses.

Among more than 77,000 first-time users, over 40,000 had quit the drug within a year. Around 18% stopped within three months, ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...

"But why does it feel so intense?" "Maybe your body is reacting to your mind's fears," I said. "Even when there's no ...

Welcome to a bonus letters column. We have several interesting questions to address, so we’ ll get right to them. --We recently wrote about precautions for using opioid pain medications and how to ...